Home › Funds › Irenic Capital Management LP › ANAB

Irenic Capital Management LP position in ANAB

ANAPTYSBIO INC · Health Care

Irenic Capital Management LP reported holding 299,215 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$15.0M, representing 0.87% of its reported portfolio and ranking #24 among its reported holdings. Irenic Capital Management LP has disclosed ANAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)299.21K sh
Reported value held$15.04M
Portfolio Weight0.87%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Irenic Capital Management LP's ANAB position evolved

Irenic Capital Management LP first disclosed a stake in ANAB in Q2 2026 at 70,447 shares (US$4.8M). The position peaked in Q3 2026 at 299,215 shares, worth US$15.0M. Across 2 filings, Irenic Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 299,215 shares valued at US$15.0M — an increase of 228,768 shares quarter over quarter.. Notable position changes include a 325% increase in Q3 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 70.45K $4.76M New
Q3 2026 299.21K $15.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC) is a Health Care company. 37 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$396.1M), TANG CAPITAL MANAGEMENT LLC (US$74.1M), Sanofi (US$41.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has Irenic Capital Management LP held ANAB?

Irenic Capital Management LP has disclosed ANAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Irenic Capital Management LP's current position in ANAB?

As of Q3 2026, Irenic Capital Management LP holds 299.21K shares of ANAB (ANAPTYSBIO INC), valued at $15.04M, representing 0.87% of its reported portfolio and ranking #24.

Has Irenic Capital Management LP been buying or selling ANAB?

In the latest 13F filing (Q3 2026), Irenic Capital Management LP increased its position in ANAB. The position peaked in Q3 2026 at 299.21K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sanofi, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.